Stay updated on Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.2 to v3.8.0; the page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-28T22:49:32.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A sitewide NIH announcement was added about updated terminology for artificial intelligence during a federal transition.
    Difference
    1%
    Check dated 2026-10-21T22:46:46.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page continues to show a 403 error instead of the study record, with the footer revision identifier updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-14T22:46:42.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1. The study record page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T22:53:37.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now returns a 403 Forbidden error, blocking access to the study details. The visible chrome (header/footer) indicates an access restriction rather than actual study content.
    Difference
    19%
    Check dated 2026-09-23T22:43:35.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Footer now displays the updated software revision from v3.6.6 to v3.7.0. This reflects a platform upgrade rather than any modification to the study data or page content.
    Difference
    0.1%
    Check dated 2026-09-16T22:16:00.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page.